On Friday, BioCentury will publish the annual Back to School essay, which builds on the articles of the week and draws an overarching picture of the stretch vision — a learning system across pre- and postmarket studies that brings more drugs to more patients in more diseases.

As the issue of accelerated approvals continues to occupy the spotlight, and forces gather to fix the flaws, we hope this package both provides a compendium of information and provokes thought and conversation about how best to maximize the potential of the pathways globally and stretch the vision of what they can to deliver for patients.

To view Friday's Back to School content, click on the links below:

Stretching the vision of accelerated approval

A learning system across pre and postmarket studies, bringing more drugs to more patients in more diseases